Experience using Phenotropil in combined treatment of multiple sclerosis
Observational study · 2010
- What was studied
- 39 patients with relapsing or secondary-progressive multiple sclerosis
- Main finding
- The report examines asthenia, mood and quality-of-life measures during adjunctive treatment. Most participants also received disease-modifying therapy.
Study data at a glance
- Participants or experimental model
- 39 patients with relapsing or secondary-progressive multiple sclerosis
- Reported results
- The report examines asthenia, mood and quality-of-life measures during adjunctive treatment. Most participants also received disease-modifying therapy.
Study limitations and source details
Study limitations
- Uncontrolled adjunctive design; treatment contributions cannot be separated.
- The host labels the reprint as Atmosfera, No. 4, 2010; earlier reprints circulate and edition matching remains open.
Source details
Original study text in a medical-portal reprint checked; publication edition not independently matched.
Sources checked
Citation
D. V. Sazonov, O. V. Ryabukhina, E. V. Bulatova, N. A. Malkova, A. V. Babenko. Experience using Phenotropil in combined treatment of multiple sclerosis Atmosfera. Nervnye bolezni. No. 4, 2010, as labeled by host